Actuate Therapeutics Inc (ACTU)
R&D Expenses
$8.94M
TTM · Period ending: · USD
ACTU R&D Expenses
Latest reported$8.94Mperiod ending
Latest reported$8.94Mperiod ending
ACTU R&D Expenses ($16.39M → $8.94M)
Annual R&D Expenses
High-resolution chart · PNG
ACTU r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 10,292,620 | |
| 18,676,276 | |
| 21,708,332 | |
| 16,387,216 |